BioSpace News Archive

RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies 2020 Virtual Global Healthcare Conference on Tuesday, June 2, 2020 at 1:30 p.m. Eastern Time.

Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced that the Company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020 at 3:00 p.m. ET.

ChromaDex Corp. announced it has organized a virtual symposium entitled “Nicotinamide Adenine Dinucleotide in Human Health and Disease: The State of the Science on Nutrition Interventions” tomorrow Tuesday, June 2, from 8:30 to 10:00 AM EDT at NUTRITION 2020 LIVE ONLINE, the annual meeting hosted by the American Society for Nutrition.

Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, will hold its 2020 Annual Meeting of Stockholders in a virtual meeting format on Wednesday, June 3, 2020 at 10:00 a.m. (Eastern Time) at www.viewproxy.com/AnnovisBio/2020/VM . Shareholders of record that attend the Annual Meeting will be able to vote and submit ques

Invacare Corporation entered into separate, privately negotiated agreements with certain holders of its 5.0% Convertible Senior Notes due 2021 and certain holders of its 4.5% Convertible Senior Notes due 2022 to exchange approximately $32.9 million in aggregate principal amount of 2021 Notes and $38.5 million in aggregate principal amount of 2022 Notes...

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, announced today the appointment of James C. D’Arecca as the Company’s Chief Financial Officer, effective June 1, 2020. Mr. D’Arecca succeeds Daniel A. Cartwright, who has retired from his position as the Company’s Chief Financial Officer, also effective June 1, 2020. Mr. Cartwright will remain with the Company as an advisor for a transitional

Company believes District Court decision misinterprets federal law and fails to address important legal requirements of the Administrative Procedure Act

Only PARP Inhibitor to Demonstrate Patient Benefit in a Phase 3 Trial in This Setting

Tool provides electrophysiologists with first-ever local measurement and visualization of tissue response to radiofrequency ablation

TriSalus Life Sciences, a company committed to transforming outcomes for patients with solid tumors, announced the appointment of Rajesh B. Mistry as Chief Financial Officer.